Annual FCF:
-$42.59M-$84.53M(-201.54%)Summary
- As of today, ALNY annual free cash flow is -$42.59 million, with the most recent change of -$84.53 million (-201.54%) on December 31, 2024.
- During the last 3 years, ALNY annual free cash flow has risen by +$675.48 million (+94.07%).
- ALNY annual free cash flow is now -122.57% below its all-time high of $188.73 million, reached on December 31, 2007.
Performance
ALNY Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
$139.44M+$266.72M(+209.55%)Summary
- As of today, ALNY quarterly free cash flow is $139.44 million, with the most recent change of +$266.72 million (+209.55%) on June 30, 2025.
- Over the past year, ALNY quarterly free cash flow has increased by +$23.30 million (+20.06%).
- ALNY quarterly free cash flow is now -59.27% below its all-time high of $342.32 million, reached on September 30, 2023.
Performance
ALNY Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$52.09M+$23.30M(+30.90%)Summary
- As of today, ALNY TTM free cash flow is -$52.09 million, with the most recent change of +$23.30 million (+30.90%) on June 30, 2025.
- Over the past year, ALNY TTM free cash flow has dropped by -$370.96 million (-116.34%).
- ALNY TTM free cash flow is now -116.34% below its all-time high of $318.87 million, reached on June 30, 2024.
Performance
ALNY TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ALNY Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -201.5% | +20.1% | -116.3% |
| 3Y3 Years | +94.1% | +200.4% | +92.1% |
| 5Y5 Years | +89.8% | +191.7% | +93.3% |
ALNY Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -201.5% | +94.1% | -59.3% | +177.3% | -116.3% | +91.8% |
| 5Y | 5-Year | -201.5% | +94.1% | -59.3% | +155.2% | -116.3% | +93.3% |
| All-Time | All-Time | -122.6% | +94.1% | -59.3% | +152.5% | -116.3% | +94.0% |
ALNY Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $139.44M(+209.5%) | -$52.09M(+30.9%) |
| Mar 2025 | - | -$127.28M(-22.7%) | -$75.39M(-77.0%) |
| Dec 2024 | -$42.59M(-201.5%) | -$103.76M(-362.6%) | -$42.59M(-365.1%) |
| Sep 2024 | - | $39.52M(-66.0%) | $16.06M(-95.0%) |
| Jun 2024 | - | $116.14M(+222.9%) | $318.87M(+149.5%) |
| Mar 2024 | - | -$94.49M(-109.5%) | $127.82M(+204.7%) |
| Dec 2023 | $41.95M(+106.8%) | -$45.10M(-113.2%) | $41.95M(+163.0%) |
| Sep 2023 | - | $342.32M(+557.0%) | -$66.56M(+87.7%) |
| Jun 2023 | - | -$74.91M(+58.5%) | -$540.68M(+10.6%) |
| Mar 2023 | - | -$180.37M(-17.4%) | -$604.65M(+1.4%) |
| Dec 2022 | -$613.33M(+14.6%) | -$153.61M(-16.6%) | -$613.33M(+2.9%) |
| Sep 2022 | - | -$131.79M(+5.1%) | -$631.75M(+4.3%) |
| Jun 2022 | - | -$138.87M(+26.5%) | -$660.05M(-0.9%) |
| Mar 2022 | - | -$189.05M(-9.9%) | -$654.28M(+8.9%) |
| Dec 2021 | -$718.07M(-4.8%) | -$172.03M(-7.5%) | -$718.07M(-3.9%) |
| Sep 2021 | - | -$160.10M(-20.3%) | -$690.85M(-5.7%) |
| Jun 2021 | - | -$133.10M(+47.4%) | -$653.50M(+2.8%) |
| Mar 2021 | - | -$252.84M(-74.6%) | -$672.38M(+1.9%) |
| Dec 2020 | -$685.32M(-63.7%) | -$144.81M(-18.0%) | -$685.32M(+11.6%) |
| Sep 2020 | - | -$122.74M(+19.2%) | -$775.29M(+11.0%) |
| Jun 2020 | - | -$151.99M(+42.8%) | -$871.24M(-92.8%) |
| Mar 2020 | - | -$265.78M(-13.2%) | -$451.80M(-7.9%) |
| Dec 2019 | -$418.58M(+39.3%) | -$234.78M(-7.4%) | -$418.58M(-12.6%) |
| Sep 2019 | - | -$218.69M(-181.8%) | -$371.77M(-5.5%) |
| Jun 2019 | - | $267.45M(+215.0%) | -$352.30M(+52.7%) |
| Mar 2019 | - | -$232.56M(-23.7%) | -$745.14M(-8.1%) |
| Dec 2018 | -$689.50M(-41.6%) | -$187.97M(+5.6%) | -$689.50M(-10.3%) |
| Sep 2018 | - | -$199.22M(-58.9%) | -$625.30M(-13.7%) |
| Jun 2018 | - | -$125.39M(+29.1%) | -$550.13M(-4.3%) |
| Mar 2018 | - | -$176.92M(-42.9%) | -$527.43M(-8.3%) |
| Dec 2017 | -$487.00M(-30.8%) | -$123.77M(+0.2%) | -$487.00M(-5.5%) |
| Sep 2017 | - | -$124.04M(-20.8%) | -$461.44M(-6.5%) |
| Jun 2017 | - | -$102.70M(+24.8%) | -$433.23M(-4.8%) |
| Mar 2017 | - | -$136.48M(-39.0%) | -$413.30M(-11.0%) |
| Dec 2016 | -$372.26M(-84.2%) | -$98.22M(-2.5%) | -$372.26M(-12.7%) |
| Sep 2016 | - | -$95.83M(-15.8%) | -$330.20M(-11.9%) |
| Jun 2016 | - | -$82.77M(+13.3%) | -$295.21M(-9.7%) |
| Mar 2016 | - | -$95.44M(-69.9%) | -$269.16M(-33.2%) |
| Dec 2015 | -$202.09M(-15.7%) | -$56.16M(+7.7%) | -$202.09M(-8.6%) |
| Sep 2015 | - | -$60.84M(-7.3%) | -$186.09M(-10.0%) |
| Jun 2015 | - | -$56.72M(-100.0%) | -$169.15M(-5.1%) |
| Mar 2015 | - | -$28.36M(+29.4%) | -$160.90M(+7.8%) |
| Dec 2014 | -$174.60M | -$40.16M(+8.5%) | -$174.60M(-10.7%) |
| Sep 2014 | - | -$43.90M(+9.4%) | -$157.69M(-15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | -$48.48M(-15.2%) | -$136.45M(-21.9%) |
| Mar 2014 | - | -$42.06M(-80.9%) | -$111.96M(-54.1%) |
| Dec 2013 | -$72.66M(+41.4%) | -$23.25M(-2.6%) | -$72.66M(+38.9%) |
| Sep 2013 | - | -$22.66M(+5.5%) | -$119.01M(-22.9%) |
| Jun 2013 | - | -$23.98M(-765.7%) | -$96.87M(-0.6%) |
| Mar 2013 | - | -$2.77M(+96.0%) | -$96.25M(+22.4%) |
| Dec 2012 | -$123.96M(-40.3%) | -$69.60M(>-9900.0%) | -$123.96M(-54.9%) |
| Sep 2012 | - | -$517.00K(+97.8%) | -$80.04M(+26.4%) |
| Jun 2012 | - | -$23.36M(+23.3%) | -$108.81M(+3.3%) |
| Mar 2012 | - | -$30.48M(-18.7%) | -$112.50M(-27.3%) |
| Dec 2011 | -$88.36M(+0.8%) | -$25.68M(+12.3%) | -$88.36M(-4.9%) |
| Sep 2011 | - | -$29.29M(-8.3%) | -$84.20M(-5.2%) |
| Jun 2011 | - | -$27.05M(-327.2%) | -$80.02M(-1.7%) |
| Mar 2011 | - | -$6.33M(+70.6%) | -$78.71M(+11.6%) |
| Dec 2010 | -$89.07M(-15.5%) | -$21.53M(+14.3%) | -$89.07M(-4.0%) |
| Sep 2010 | - | -$25.11M(+2.5%) | -$85.68M(-4.6%) |
| Jun 2010 | - | -$25.74M(-54.2%) | -$81.90M(+12.1%) |
| Mar 2010 | - | -$16.70M(+7.9%) | -$93.14M(-20.8%) |
| Dec 2009 | -$77.09M(-240.9%) | -$18.13M(+15.0%) | -$77.09M(-18.4%) |
| Sep 2009 | - | -$21.32M(+42.3%) | -$65.09M(-4.9%) |
| Jun 2009 | - | -$36.98M(-5554.6%) | -$62.06M(-194.5%) |
| Mar 2009 | - | -$654.00K(+89.3%) | $65.68M(+20.0%) |
| Dec 2008 | $54.73M(-71.0%) | -$6.13M(+66.5%) | $54.73M(+13.6%) |
| Sep 2008 | - | -$18.29M(-120.2%) | $48.19M(-83.4%) |
| Jun 2008 | - | $90.75M(+882.2%) | $290.08M(+53.1%) |
| Mar 2008 | - | -$11.60M(+8.4%) | $189.44M(+0.4%) |
| Dec 2007 | $188.73M(+737.3%) | -$12.67M(-105.7%) | $188.73M(-4.0%) |
| Sep 2007 | - | $223.60M(+2361.8%) | $196.50M(+738.3%) |
| Jun 2007 | - | -$9.89M(+19.7%) | -$30.78M(+3.0%) |
| Mar 2007 | - | -$12.31M(-151.1%) | -$31.74M(-7.2%) |
| Dec 2006 | -$29.62M(-60.7%) | -$4.90M(-33.3%) | -$29.62M(-36.5%) |
| Sep 2006 | - | -$3.68M(+66.1%) | -$21.70M(+11.8%) |
| Jun 2006 | - | -$10.85M(-6.5%) | -$24.60M(-20.8%) |
| Mar 2006 | - | -$10.19M(-437.8%) | -$20.37M(-10.5%) |
| Dec 2005 | -$18.43M(+35.5%) | $3.02M(+145.8%) | -$18.43M(+22.7%) |
| Sep 2005 | - | -$6.58M(+0.5%) | -$23.85M(-8.1%) |
| Jun 2005 | - | -$6.62M(+19.7%) | -$22.06M(+15.8%) |
| Mar 2005 | - | -$8.25M(-242.9%) | -$26.19M(+8.4%) |
| Dec 2004 | -$28.58M(-79.2%) | -$2.40M(+49.8%) | -$28.58M(-9.2%) |
| Sep 2004 | - | -$4.79M(+55.4%) | -$26.17M(-22.4%) |
| Jun 2004 | - | -$10.75M(-1.1%) | -$21.38M(-101.1%) |
| Mar 2004 | - | -$10.63M | -$10.63M |
| Dec 2003 | -$15.95M(-766.7%) | - | - |
| Dec 2002 | -$1.84M | - | - |
FAQ
- What is Alnylam Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Alnylam Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Alnylam Pharmaceuticals, Inc.?
- What is Alnylam Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Alnylam Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of ALNY is -$42.59M
What is the all-time high annual free cash flow for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high annual free cash flow is $188.73M
What is Alnylam Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, ALNY annual free cash flow has changed by -$84.53M (-201.54%)
What is Alnylam Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of ALNY is $139.44M
What is the all-time high quarterly free cash flow for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high quarterly free cash flow is $342.32M
What is Alnylam Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, ALNY quarterly free cash flow has changed by +$23.30M (+20.06%)
What is Alnylam Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of ALNY is -$52.09M
What is the all-time high TTM free cash flow for Alnylam Pharmaceuticals, Inc.?
Alnylam Pharmaceuticals, Inc. all-time high TTM free cash flow is $318.87M
What is Alnylam Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, ALNY TTM free cash flow has changed by -$370.96M (-116.34%)